Φορτώνει......
Nivolumab-induced immune-mediated neurotoxicity in Hodgkin lymphoma
Nivolumab, a monoclonal antibody against programmed cell death-1 used to treat multiple cancers, has fewer side effects than traditional chemotherapy but has displayed a propensity to cause a host of immune-related adverse events. We describe a case of nivolumab immune-mediated neurotoxicity in a 42...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Proc (Bayl Univ Med Cent) |
|---|---|
| Κύριοι συγγραφείς: | , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Taylor & Francis
2019
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6988700/ https://ncbi.nlm.nih.gov/pubmed/32063772 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/08998280.2019.1668719 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|